These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16817242)

  • 1. Binding capacity differences for antibodies and Fc-fusion proteins on protein A chromatographic materials.
    Ghose S; Hubbard B; Cramer SM
    Biotechnol Bioeng; 2007 Mar; 96(4):768-79. PubMed ID: 16817242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and comparison of alternatives to Protein A chromatography Mimetic and hydrophobic charge induction chromatographic stationary phases.
    Ghose S; Hubbard B; Cramer SM
    J Chromatogr A; 2006 Jul; 1122(1-2):144-52. PubMed ID: 16750212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein aggregation kinetics during Protein A chromatography. Case study for an Fc fusion protein.
    Shukla AA; Gupta P; Han X
    J Chromatogr A; 2007 Nov; 1171(1-2):22-8. PubMed ID: 17920607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and optimization of a dual-flowrate loading strategy to maximize throughput in protein-a affinity chromatography.
    Ghose S; Nagrath D; Hubbard B; Brooks C; Cramer SM
    Biotechnol Prog; 2004; 20(3):830-40. PubMed ID: 15176889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanistic study of Protein A chromatography resin lifetime.
    Jiang C; Liu J; Rubacha M; Shukla AA
    J Chromatogr A; 2009 Jul; 1216(31):5849-55. PubMed ID: 19539295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silica-based solid phases for affinity chromatography: Effect of pore size and ligand location upon biochemical productivity.
    Mohan SB; Lyddiatt A
    Biotechnol Bioeng; 1992 Aug; 40(5):549-63. PubMed ID: 18601151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of silica-based media for antibody purification by protein A affinity chromatography.
    Katoh S; Imada M; Takeda N; Katsuda T; Miyahara H; Inoue M; Nakamura S
    J Chromatogr A; 2007 Aug; 1161(1-2):36-40. PubMed ID: 17467720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody variable region interactions with Protein A: implications for the development of generic purification processes.
    Ghose S; Allen M; Hubbard B; Brooks C; Cramer SM
    Biotechnol Bioeng; 2005 Dec; 92(6):665-73. PubMed ID: 16206278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of an Fc-fusion biologic: clearance of multiple product related impurities by hydrophobic interaction chromatography.
    Evans DR; Macniven RP; Labanca M; Walker J; Notarnicola SM
    J Chromatogr A; 2008 Jan; 1177(2):265-71. PubMed ID: 17692855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology.
    Huang C
    Curr Opin Biotechnol; 2009 Dec; 20(6):692-9. PubMed ID: 19889530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a novel methacrylate-based Protein A resin for the purification of immunoglobulins and Fc-fusion proteins.
    McCaw TR; Koepf EK; Conley L
    Biotechnol Prog; 2014; 30(5):1125-36. PubMed ID: 25045034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomerization is required for the activity of recombinant soluble LOX-1.
    Cao W; Calabro V; Root A; Yan G; Lam K; Olland S; Sanford J; Robak A; Zollner R; Lu Z; Ait-Zahra M; Agostinelli R; Tchistiakova L; Gill D; Harnish D; Paulsen J; Shih HH
    FEBS J; 2009 Sep; 276(17):4909-20. PubMed ID: 19664054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downstream processing of monoclonal antibodies--application of platform approaches.
    Shukla AA; Hubbard B; Tressel T; Guhan S; Low D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):28-39. PubMed ID: 17046339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inexpensive and generic affinity purification of recombinant proteins using a family 2a CBM fusion tag.
    Rodriguez B; Kavoosi M; Koska J; Creagh AL; Kilburn DG; Haynes CA
    Biotechnol Prog; 2004; 20(5):1479-89. PubMed ID: 15458333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the binding capacities of protein A chromatographic materials by means of ligand polymerization.
    Freiherr von Roman M; Berensmeier S
    J Chromatogr A; 2014 Jun; 1347():80-6. PubMed ID: 24819019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening of chromatographic separations: I. Method development and column modeling.
    Coffman JL; Kramarczyk JF; Kelley BD
    Biotechnol Bioeng; 2008 Jul; 100(4):605-18. PubMed ID: 18496874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of rhEpo-Fc fusion protein expressed in CHO cells.
    Schriebl K; Trummer E; Lattenmayer C; Weik R; Kunert R; Müller D; Katinger H; Vorauer-Uhl K
    Protein Expr Purif; 2006 Oct; 49(2):265-75. PubMed ID: 16861003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding affinity of a soluble TCR-Fc fusion protein is significantly improved by crosslinkage with an anti-Cβ antibody.
    Ozawa T; Horii M; Kobayashi E; Jin A; Kishi H; Muraguchi A
    Biochem Biophys Res Commun; 2012 Jun; 422(2):245-9. PubMed ID: 22575452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin specificity of TG19318: a novel synthetic ligand for antibody affinity purification.
    Fassina G; Verdoliva A; Palombo G; Ruvo M; Cassani G
    J Mol Recognit; 1998; 11(1-6):128-33. PubMed ID: 10076825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding ligand-protein interactions in affinity membrane chromatography for antibody purification.
    Boi C; Busini V; Salvalaglio M; Cavallotti C; Sarti GC
    J Chromatogr A; 2009 Dec; 1216(50):8687-96. PubMed ID: 19535082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.